Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.06    0.00 (0.00%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €295.52m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

Changes to the Board

22 May 2025 15:57

RNS Number : 8438J
CVC Income & Growth Limited
22 May 2025
 

22 May 2025

 

CVC Income & Growth Limited

(the Company or CVC)

 

Changes to the Board

 

 

The Board of the Company announces that it has agreed with Ms Stephanie Carbonneil, Senior Independent Director and Chair of the Nomination and Remuneration Committee, that she will step down from the Board due to her increasing time commitment required of her executive role.

 

To allow for an orderly handover, Ms Carbonneil will step down from the Board with effect from 21 August 2025.

 

The Company is pleased to announce that Ms Esther Gilbert has been appointed Senior Independent Director and Ms Vanessa Neill has been appointed as Chair of the Nomination and Remuneration Committee, both effective 21 August 2025.

 

Ms Neill and Ms Gilbert have served on the Board since January 2022 and September 2022 respectively.

 

The Board would like to express its sincere thanks to Ms Carbonneil for her contribution to the Board, as Senior Independent Director, and as Chair of the Nomination and Remuneration Committee over the years.

 

Robert Kirkby, Chair of the Board commented: "I would like to thank Stephanie, on behalf of the Board, for her tremendous contribution to CVC, as well as the insights and experience she has brought to her role as Chair of the Nomination and Remuneration Committee. Stephanie has been with CVC since February 2019 and with her extensive knowledge of the investment trust market has been a valuable Board member as we have advanced the Company on its trajectory of profitable growth. I wish her well in her future endeavours.

Welcoming both Esther and Vanessa to their respective leadership roles, CVC retains a strong non-executive leadership team with significant years of industry knowledge and expertise, ensuring the Company remains well positioned for growth."

 

This announcement is released in compliance with UK Listing Rule 6.4.6.

 

END

 

Enquiries:

CVC Income & Growth Limited: +44 (0)1534 815200

Robert Kirkby

BNP Paribas S.A., Jersey Branch: cvcpeolcosec@bnpparibas.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEALSAASSSEFA
Date   Source Headline
13th Jun 20245:30 pmRNSNet Asset Value Weekly to 07 Jun 2024
6th Jun 20245:00 pmRNSNet Asset Value Weekly to 31 May 2024
3rd Jun 20244:18 pmRNSTotal Voting Rights
30th May 202412:45 pmRNSNet Asset Value Weekly to 24 May 2024
23rd May 20245:15 pmRNSNet Asset Value Weekly to 17 May 2024
21st May 20249:37 amRNSMonthly Report
20th May 20241:34 pmRNSDirector Declaration
17th May 20246:07 pmRNSNet Asset Value Month End 30 Apr 2024
16th May 20243:51 pmRNSNet Asset Value Weekly to 10 May 2024
15th May 202410:49 amRNSIssue of Equity
10th May 20244:31 pmRNSNet Asset Value Weekly to 03 May 2024
3rd May 20249:04 amRNSNet Asset Value Weekly to 26 Apr 2024
1st May 202411:01 amRNSDividend Declaration
1st May 202411:01 amRNSTotal Voting Rights
1st May 20249:40 amRNSDirector/PDMR Shareholding
30th Apr 202410:47 amRNSDirectorate Change
30th Apr 202410:46 amRNSResult of AGM
25th Apr 20244:00 pmRNSNet Asset Value Weekly to 19 Apr 2024
24th Apr 20243:43 pmRNSDirector/PDMR Shareholding
23rd Apr 202412:02 pmRNSMonthly Report
22nd Apr 20244:55 pmRNSIssue of Equity
18th Apr 20244:53 pmRNSNet Asset Value Weekly to 12 Apr 2024
18th Apr 20247:00 amRNSMarch 2024 Tender Price
17th Apr 20245:09 pmRNSIssue of Equity
15th Apr 20245:07 pmRNSNet Asset Value Month End 28 Mar 2024
11th Apr 202411:45 amRNSNet Asset Value Weekly to 05 Apr 2024
10th Apr 20242:46 pmRNSNotice of AGM
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
2nd Apr 202411:27 amRNSNet Asset Value Weekly to 22 Mar 2024
28th Mar 20247:00 amRNSAnnual Financial Report
25th Mar 20244:09 pmRNSMonthly Report
21st Mar 20243:59 pmRNSNet Asset Value Weekly to 15 Mar 2024
15th Mar 20243:59 pmRNSNet Asset Value Month End 29 Feb 2024
14th Mar 20244:04 pmRNSNet Asset Value Weekly to 08 Mar 2024
7th Mar 20244:59 pmRNSNet Asset Value Weekly to 01 Mar 2024
6th Mar 20247:00 amRNSResults of Placing in respect of March 2024 Tender
28th Feb 20244:33 pmRNSNet Asset Value Weekly to 23 Feb 2024
22nd Feb 20244:11 pmRNSDirector/PDMR Shareholding
22nd Feb 20243:28 pmRNSNet Asset Value Weekly to 16 Feb 2024
20th Feb 20244:56 pmRNSMonthly Report
16th Feb 20244:16 pmRNSNet Asset Value Weekly to 09 Feb 2024
15th Feb 20241:49 pmRNSNet Asset Value Month End 31 Jan 2024
14th Feb 20241:00 pmRNSResult of Semi-Annual Tender Process
8th Feb 20244:41 pmRNSNet Asset Value Weekly to 02 Feb 2024
7th Feb 202410:22 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSIncrease in Annual Dividend Targets
2nd Feb 20244:01 pmRNSNet Asset Value Weekly to 26 Jan 2024
1st Feb 20244:05 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSAddition of Placing Shares as part of March Tender
30th Jan 20247:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.